Clinical Trials Directory

Trials / Completed

CompletedNCT00286507

Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study

Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study: Randomised Comparison of Macular Hole Surgery With or Without Internal Limiting Membrane Peeling

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
141 (actual)
Sponsor
University of Aberdeen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A macular hole is a fairly common problem in the retina and is an important cause of loss of central vision. The aim of this study is to determine whether, in patients with a stage 2 or 3 full thickness macular hole (FTMH), peeling a very fine, transparent tissue that covers the surface of the retina, called the internal limiting membrane (ILM) during surgery is superior to non-ILM peeling macular hole surgery. The main outcomes are improvement in vision, achievement of macular hole closure, need for re-operation, health related quality of life (HRQOL) and cost effectiveness.

Detailed description

Idiopathic full-thickness macular hole (FTMH) is an important cause of loss of central vision, usually leading to severe visual impairment. Up to 20% of affected people will develop a FTMH in both eyes. There is uncertainty in the literature and among vitreo-retinal surgeons about the balance of potential benefits and adverse effects of ILM peeling in FTMH surgery for stage 2-3 holes. FILMS is a randomised controlled trial (RCT) in patients with stage 2-3 FTMH less less than 18 months duration investigating whether ILM peeling improves the anatomical and visual outcome of macular hole surgery and the quality of life of patients with this retinal disease. Cost-effectiveness is also being addressed.

Conditions

Interventions

TypeNameDescription
PROCEDUREVitrectomy, post hyaloid detachment and gas injection with or without ILM peel.Combined cataract surgery (phacoemulsification and intraocular lens implantation) and pars plana vitrectomy with postoperative intraocular tamponade with gas, with or without ILM peeling

Timeline

Start date
2005-07-01
Primary completion
2009-09-01
Completion
2011-09-01
First posted
2006-02-03
Last updated
2012-06-06

Locations

9 sites across 2 countries: Ireland, United Kingdom

Source: ClinicalTrials.gov record NCT00286507. Inclusion in this directory is not an endorsement.